Market Overview - The current market rally is supported by factors such as the Federal Reserve's cutting cycle, corporate profit margins, and infrastructural investments, which are driving earnings growth [2] - Easing tariff uncertainties are also contributing positively to the market environment [2] - The labor market is showing signs of resilience, with slow hiring but no expected rise in layoffs due to strong corporate profits [3] Investment Strategy - The article discusses the Top 12 Blue Chip Stocks to buy at 52-week lows, indicating a strategy focused on stocks trading between 0% to 10% of their 52-week lows [6] - The methodology involves analyzing hedge fund holdings to identify stocks that may outperform the market [7] Company Insights Unilever PLC (NYSE:UL) - Current price is $59.17, with a 52-week range of $54.32 to $65.66 and 27 hedge fund holders [8] - The company is facing challenges in emerging markets, particularly in Latin America, which is limiting growth potential [10] - Despite difficulties in key markets like India and China, Unilever is performing moderately well in developed markets [11] Amgen Inc. (NASDAQ:AMGN) - Current price is $273.97, with a 52-week range of $253.30 to $335.88 and 62 hedge fund holders [12] - The company is increasing its manufacturing capacity in the U.S. due to tariffs on pharmaceutical imports, with a $900 million investment in Ohio and plans for a new R&D center in California [13] - Amgen is also investing $650 million to expand drug manufacturing in Puerto Rico [13]
Top 12 Blue Chip Stocks to Buy At 52-Week Lows